Free Trial
NASDAQ:NATR

Nature's Sunshine Products (NATR) Stock Price, News & Analysis

Nature's Sunshine Products logo
$12.65 +0.04 (+0.32%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$12.53 -0.12 (-0.96%)
As of 03/28/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Nature's Sunshine Products Stock (NASDAQ:NATR)

Key Stats

Today's Range
$12.43
$12.81
50-Day Range
$12.38
$15.21
52-Week Range
$10.81
$21.22
Volume
42,836 shs
Average Volume
46,947 shs
Market Capitalization
$233.82 million
P/E Ratio
14.38
Dividend Yield
N/A
Price Target
$19.00
Consensus Rating
Buy

Company Overview

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.

Remove Ads

Nature's Sunshine Products Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

NATR MarketRank™: 

Nature's Sunshine Products scored higher than 63% of companies evaluated by MarketBeat, and ranked 392nd out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nature's Sunshine Products is 14.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.57.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nature's Sunshine Products is 14.38, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.49.

  • Price to Book Value per Share Ratio

    Nature's Sunshine Products has a P/B Ratio of 1.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Nature's Sunshine Products' valuation and earnings.
  • Percentage of Shares Shorted

    0.52% of the float of Nature's Sunshine Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Nature's Sunshine Products has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nature's Sunshine Products has recently increased by 23.33%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nature's Sunshine Products does not currently pay a dividend.

  • Dividend Growth

    Nature's Sunshine Products does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Nature's Sunshine Products is 100.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Nature's Sunshine Products' dividend.
  • Percentage of Shares Shorted

    0.52% of the float of Nature's Sunshine Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Nature's Sunshine Products has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nature's Sunshine Products has recently increased by 23.33%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nature's Sunshine Products has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Nature's Sunshine Products this week, compared to 2 articles on an average week.
  • Search Interest

    3 people have searched for NATR on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nature's Sunshine Products insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.70% of the stock of Nature's Sunshine Products is held by insiders.

  • Percentage Held by Institutions

    79.40% of the stock of Nature's Sunshine Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Nature's Sunshine Products' insider trading history.
Receive NATR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter.

NATR Stock News Headlines

Nature’s Sunshine Products (NATR) Gets a Buy from D.A. Davidson
The Same Setup That Led to a 131% Gold Surge Is Happening Now
Historically, when confidence in credit markets gets too high, a gold acceleration phase follows… And we’re seeing the same setup playing out again… With central banks piling into gold, inflation lingering, and debt levels soaring, I believe we’re on the verge of another Gold acceleration cycle—and it could happen fast. Back in November, I told folks to “buy the dip” in gold and I sure hope they listened… I cannot promise future returns or against losses, but now I’m giving you another heads-up… I broke down exactly what I am seeing and how anyone with a regular brokerage account can take advantage… Without actually holding any gold…
Nature’s Sunshine initiatives driving sales growth, says Canaccord
See More Headlines

NATR Stock Analysis - Frequently Asked Questions

Nature's Sunshine Products' stock was trading at $14.66 at the start of the year. Since then, NATR shares have decreased by 13.7% and is now trading at $12.65.
View the best growth stocks for 2025 here
.

Nature's Sunshine Products, Inc. (NASDAQ:NATR) announced its quarterly earnings data on Thursday, November, 7th. The company reported $0.27 EPS for the quarter. The business had revenue of $114.62 million for the quarter. Nature's Sunshine Products had a net margin of 3.81% and a trailing twelve-month return on equity of 11.08%.

Top institutional shareholders of Nature's Sunshine Products include Fosun International Ltd (15.79%), Dimensional Fund Advisors LP (4.64%), Paradigm Capital Management Inc. NY (4.43%) and Renaissance Technologies LLC (2.93%). Insiders that own company stock include Wynnefield Partners Small Cap, Bryant J Yates, Daniel C Norman, Fosun Pharmaceutical Shanghai and Nathan G Brower.
View institutional ownership trends
.

Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nature's Sunshine Products investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), e.l.f. Beauty (ELF), Jabil (JBL), Meta Platforms (META) and Disc Medicine (IRON).

Company Calendar

Last Earnings
11/07/2024
Today
3/29/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
Current Symbol
NASDAQ:NATR
Employees
850
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$19.00
High Stock Price Target
$21.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+50.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
14.38
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$15.08 million
Pretax Margin
5.54%

Debt

Sales & Book Value

Annual Sales
$454.36 million
Cash Flow
$1.45 per share
Price / Cash Flow
8.73
Book Value
$8.36 per share
Price / Book
1.51

Miscellaneous

Free Float
17,608,000
Market Cap
$233.82 million
Optionable
Optionable
Beta
0.91
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:NATR) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners